human crbp1 complementary deoxyribonucleic acid (gene number nm-002899) (OriGene)
Structured Review
![Stimulated by retinoic acid 6 (STRA6) cascades decrease and markers of atherosclerosis increase in the aortas of electronegative low‐density lipoprotein (L5)‐injected mice. The protein of aorta samples ( n = 3) was extracted from saline‐injected (control [Ctl]), L1‐injected (L1) and L5‐injected (L5) mice, as well as L5‐injected LOX1 −/− mice (LOX1 −/− +L5) after injection for 4 weeks. (a) Western blots showed that L5 decreased aortic STRA6, cellular retinol‐binding protein 1 <t>(CRBP1),</t> lecithin‐retinol acyltransferase (LRAT), retinoic acid receptor (RAR)α and retinoid X receptor (RXR)α, but increased aortic LOX1, p‐p38 mitogen‐activated protein kinases (p‐p38), pSmad2, transforming grown factor‐β 1 (TGFβ 1 ), caspase 3 (Casp3) and matrix metallopeptidase 9 (MMP9) in L5‐injected mice. In LOX1 −/− mice, these changes caused by L5 were ameliorated. (b) Bar graphs showed that LOX1 increased, and STRA6, CRBP1, LRAT, RARα and RXRα decreased in L5‐injected mice. These changes caused by L5 were recovered in L5‐injected LOX1 −/− mice. (c) Bar graphs show that the p‐p38/p38 and pSmad2/Smad2 ratio increased in L5‐injected mice. These changes were reversed in L5‐injected LOX1 −/− mice. (d) TGFβ 1 , caspase 3 and MMP9 levels of L5‐injected mice increased. These changes were also recovered in L5‐injected LOX1 −/− mice. All results are presented as the mean ± standard error. * P < 0.05 versus Ctl and L1; # P < 0.05 versus L5. WT, wild‐type.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2312/pmc07232312/pmc07232312__JDI-11-535-g001.jpg)
Human Crbp1 Complementary Deoxyribonucleic Acid (Gene Number Nm 002899), supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human crbp1 complementary deoxyribonucleic acid (gene number nm-002899)/product/OriGene
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Electronegative low‐density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade"
Article Title: Electronegative low‐density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade
Journal: Journal of Diabetes Investigation
doi: 10.1111/jdi.13158
Figure Legend Snippet: Stimulated by retinoic acid 6 (STRA6) cascades decrease and markers of atherosclerosis increase in the aortas of electronegative low‐density lipoprotein (L5)‐injected mice. The protein of aorta samples ( n = 3) was extracted from saline‐injected (control [Ctl]), L1‐injected (L1) and L5‐injected (L5) mice, as well as L5‐injected LOX1 −/− mice (LOX1 −/− +L5) after injection for 4 weeks. (a) Western blots showed that L5 decreased aortic STRA6, cellular retinol‐binding protein 1 (CRBP1), lecithin‐retinol acyltransferase (LRAT), retinoic acid receptor (RAR)α and retinoid X receptor (RXR)α, but increased aortic LOX1, p‐p38 mitogen‐activated protein kinases (p‐p38), pSmad2, transforming grown factor‐β 1 (TGFβ 1 ), caspase 3 (Casp3) and matrix metallopeptidase 9 (MMP9) in L5‐injected mice. In LOX1 −/− mice, these changes caused by L5 were ameliorated. (b) Bar graphs showed that LOX1 increased, and STRA6, CRBP1, LRAT, RARα and RXRα decreased in L5‐injected mice. These changes caused by L5 were recovered in L5‐injected LOX1 −/− mice. (c) Bar graphs show that the p‐p38/p38 and pSmad2/Smad2 ratio increased in L5‐injected mice. These changes were reversed in L5‐injected LOX1 −/− mice. (d) TGFβ 1 , caspase 3 and MMP9 levels of L5‐injected mice increased. These changes were also recovered in L5‐injected LOX1 −/− mice. All results are presented as the mean ± standard error. * P < 0.05 versus Ctl and L1; # P < 0.05 versus L5. WT, wild‐type.
Techniques Used: Injection, Saline, Control, Western Blot, Binding Assay
Figure Legend Snippet: Electronegative low‐density lipoprotein (L5) suppresses stimulated by retinoic acid 6 (STRA6) cascades and induces markers of atherosclerosis in human aortic endothelial cell lines (HAECs). (a) Western blots showed the expression of LOX1, STRA6, cellular retinol‐binding protein 1 (CRBP1), lecithin‐retinol acyltransferase (LRAT), retinoic acid receptor (RAR)α, retinoid X receptor (RXR)α, p‐p38 mitogen‐activated protein kinases (p‐p38), pSmad2, and matrix metallopeptidase 9 (MMP9) in control small interfering ribonucleic acid (siC)‐transfected and LOX1 small interfering ribonucleic acid (siLOX1)‐transfected HAECs ( n = 3) after phosphate‐buffered saline (control [Ctl]), L1 or L5 treatment for 24 h. In L5‐treated HAECs, the quantitative analysis showed that (b) LOX1 protein level significantly increased; but (c) protein levels of STRA6, (d) CRBP1, (e) LRAT, (f) RARα and (g) RXRα decreased; (h) p‐p38/p38 and (i) pSmad2/Smad2 ratios increased; and (j) protein level of MMP9 increased. These changes were reversed in LOX1 small interfering ribonucleic acid‐transfected HAECs under L5 treatment. All results are presented as the mean ± standard error. * P < 0.05 versus Ctl‐ and L1‐treated siC group; # P < 0.05 versus L5‐treated siC group.
Techniques Used: Western Blot, Expressing, Binding Assay, Control, Transfection, Saline
Figure Legend Snippet: Electronegative low‐density lipoprotein (L5) suppresses stimulated by retinoic acid 6 (STRA6) cascades and enhances markers of atherosclerosis in human aortic smooth muscle cell lines (HASMCs). (a) Western blots showed LOX1, STRA6, cellular retinol‐binding protein 1 (CRBP1), lecithin‐retinol acyltransferase (LRAT), retinoic acid receptor (RAR)α, retinoid X receptor (RXR)α, p‐p38 mitogen‐activated protein kinases (p‐p38), p‐Smad2 and matrix metallopeptidase 9 (MMP9) protein expression in control small interfering ribonucleic acid (siC)‐transfected and LOX1 small interfering ribonucleic acid (siLOX1)‐transfected HASMCs ( n = 3) after phosphate‐buffered saline (control [Ctl]), L1 or L5 treatment for 24 h. Quantitative analysis showed that L5 treatment (b) increased LOX1, (c) decreased STRA6, (d) CRBP1, (e) LRAT, (f) RARα and (g) RXRα protein levels, but (h) increased p‐38/p38 and (i) pSmad2/Smad2 ratios, and (j) MMP9 protein level as compared to phosphate‐buffered saline‐ and L1‐treated cells. All these effects of L5 in siC‐transfected cells were reversed in LOX1 small interfering ribonucleic acid‐transfected HASMCs under L5 stimulation. All results were presented as the mean ± standard error. * P < 0.05 versus Ctl‐ and L1‐treated siC group; # P < 0.05 versus L5‐treated siC group.
Techniques Used: Western Blot, Binding Assay, Expressing, Control, Transfection, Saline
Figure Legend Snippet: The crbp1 gene transfection reverses electronegative low‐density lipoprotein (L5) effects on stimulated by retinoic acid 6 (STRA6) cascades and markers of atherosclerosis in human aortic endothelial cell lines (HAECs). (a) Western blots showed LOX1, STRA6, cellular retinol‐binding protein 1 (CRBP1), lecithin‐retinol acyltransferase (LRAT), retinoic acid receptor (RAR)α, retinoid X receptor (RXR), p38 mitogen‐activated protein kinases (p‐38), pSmad2 and matrix metallopeptidase 9 (MMP9) expression in cell lysate of pCMV6‐transfected and pCMV6‐crbp1‐transfected HAECs under phosphate‐buffered saline (control [Ctl]), L1 and L5 treatment for 24 h ( n = 3). Quantitative analysis showed significant differences for (b) the increase of LOX1; the decrease of (c) STRA6, (d) CRBP1, (e) LRAT, (f) RARα and (g) RXRα; the increase of (h) p‐p38/p38 and (i) pSmad2/Smad2 ratios, and (j) MMP9 under L5 stimulation in pCMV6‐transfected cells. These changes caused by L5 treatment were reversed in pCMV6‐crbp1‐transfected cells. All results are presented as the mean ± standard error. * P < 0.05 versus Ctl‐ and L1‐treated plasmid DNA of cytomegalovirus 6 (pCMV6) groups; # P < 0.05 versus L5‐treated pCMV6 group.
Techniques Used: Transfection, Western Blot, Binding Assay, Expressing, Saline, Control, Plasmid Preparation
